References
- Special Systematic Reviews 2009 Current status of Liver Diseases in Korea: Report from the Epidemiology Study Group of the KASL. Annual report of Korean central cancer registry program, Ministry of Health and Welfare, Republic of Korea 2002.
- Kim JH, Choi MS, Lee H, et al. Clinical features and prognosis of Hepatocerullar carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 2006;21: 588-594. https://doi.org/10.1111/j.1440-1746.2005.04127.x
- Huh K, Choi SY, Whang YS, Lee DS. Prevalence of viral hepatitis markers in Korean patients with hepatocerullar carcinoma. J Korean Med Sci 1998;13:306-310. https://doi.org/10.3346/jkms.1998.13.3.306
- Ministry of Health and Welfare. Korea Central Cancer Registry. Cancer incidence in Korea, 2007.
- Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocerullar carcinoma compared with hepatitis B virus in elderly patients in a hepatitis Bendemic area. Cancer 1993;72:2564-2567. https://doi.org/10.1002/1097-0142(19931101)72:9<2564::AID-CNCR2820720909>3.0.CO;2-#
- Jung SH, Kim BH, Joung YH, et al. Clinical features of hepatocerullar carcinoma in the 1990s. Korean J Gastroenterol 2003;42:322-329.
- Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocerullar carcinoma in a hepatitis B virus endemic area. J Gastroenterol Hepatol 2008;23:467-473. https://doi.org/10.1111/j.1440-1746.2007.05112.x
- Lee HS, Ryu JK, Jung SH, Kim YC. A prospective study on the incidence and the risk factors ofThe development of hepatocerullar carcinoma in patients with the liver cirrhosis in Korea. Korean J Gastroenterol 1993;25:116-122.
- Han BH, Lee SW, Koo JY, Park BC. Prevalence of hepatitis B and C viral markers in patients with hepatocerullar carcinoma in Korea. J Korean Cancer Assoc 1991;23:723-727.
- Huh K, Lee JK, Choi SY, Hong SI, Lee DS. A study on the prevalence of HBsAg and anti-HCV in patients with hepatocerullar carcinoma: comparative study with healthy blood donors. Korean J Clin Pathol 1998;18:458-463.
- Park JW. Practice guideline for diagnosis and treatment of hepatocerullar carcinoma. Korean J Hepatol 2004;10:88-98.
- Lee JG, Kang CM, Park JS, et al. The actual five-year survival rate of hepatocerullar carcinoma patients after curative resection. Yonsei Med J 2006;47:105-112. https://doi.org/10.3349/ymj.2006.47.1.105
- Wang HJ, Lee H. Surgical treatment of hepatocerullar carcinoma. Korean J Gastroenterol 2005;45:247-257.
- Kim HJ, Hwang YJ, Kim JY, et al. Comparision of surgical outcomes and long-term survival between limited and major hepatic resection for hepatocerullar carcinoma less than 5 cm. J Korean Surg Soc 2010;78:29-34. https://doi.org/10.4174/jkss.2010.78.1.29
- Poon RT, Ng IO, Fan ST, et al. Clinicopathologic features of long-term survivors and disease- free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol 2001;19: 3037-3044. https://doi.org/10.1200/JCO.2001.19.12.3037
- Choi SB, Kim KS, Park YN, et al. The efficacy of hepatic resection after neoadjuvant transarterial chemoembolization (TACE) and radiation therapy in hepatocellular carcinoma greater than 5 cm in size. J Korean Med Sci 2009;24:242-247. https://doi.org/10.3346/jkms.2009.24.2.242
- Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009;249:195-202. https://doi.org/10.1097/SLA.0b013e3181961c16